CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo†Maria A. González-Carmona, Volker Schmitz, Veronika Lukacs‐Kornek et al.|Hepatology|2008Cited by 67
Improving immunotherapy of hepatocellular carcinoma (<scp>HCC</scp>) using dendritic cells (<scp>DC</scp>) engineered to express <scp>IL</scp>‐12 <i>in vivo</i>Annabelle Vogt, Maria A. González-Carmona, Veronika Lukacs‐Kornek et al.|Liver International|2013Cited by 30
Increase of In Vivo Antitumoral Activity by CD40L (CD154) Gene Transfer Into Pancreatic Tumor Cell-Dendritic Cell HybridsCarsten Ziske, Ingo G.H. Schmidt‐Wolf, Patricia E. Etzrodt et al.|Pancreas|2009Cited by 13
309 CYTOTOXIC ACTIVITY OF IMMUNOLOGIC EFFECTOR CELLS INDUCED AGAINST HCC BY AFP- OR TUMOR LYSATE-PULSED DENDRITIC CELLS CAN BE SIGNIFICANTLY ENHANCED BY ADENOVIRAL TRANSDUCTION WITH IL-12Maria A. González-Carmona, Wolfgang H. Caselmann, Anne B. Vogt et al.|Journal of Hepatology|2009Cited by 0
375 Dendritic cells co-transduced with an interleukin (IL)-12- or CD40L-expressing adenovirus and an AFP-encoding adenovirus enhance the cytotoxic activity of immunologic effector cells against AFP-expressing HCC cellsMaria A. González-Carmona, Wolfgang H. Caselmann, A. Timmerman et al.|Journal of Hepatology|2006Cited by 0